Back to Archived Journals » Core Evidence » Volume 9 » default

Core Evidence ceased publishing in February 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.

Archive: Volume 9, 2014

Luliconazole for the treatment of fungal infections: an evidence-based review

Khanna D, Bharti S

Core Evidence 2014, 9:113-124

Published Date: 24 September 2014

Brodalumab: an evidence-based review of its potential in the treatment of moderate-to-severe psoriasis

Coimbra S, Figueiredo A, Santos-Silva A

Core Evidence 2014, 9:89-97

Published Date: 21 July 2014

Clinical utility of treprostinil in the treatment of pulmonary arterial hypertension: an evidence-based review

Buckley MS, Berry AJ, Kazem NH, Patel SA, Librodo PA

Core Evidence 2014, 9:71-80

Published Date: 20 June 2014

Development of cabozantinib for the treatment of prostate cancer [Corrigendum]

Vaishampayan UN

Core Evidence 2014, 9:69-70

Published Date: 16 May 2014

Development of cabozantinib for the treatment of prostate cancer

Vaishampayan UN

Core Evidence 2014, 9:61-67

Published Date: 23 April 2014

Eptifibatide: The evidence for its role in the management of acute coronary syndromes [Corrigendum]

Shah I, Khan SO, Malhotra S, Fischell T

Core Evidence 2014, 9:49-50

Published Date: 14 March 2014

Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis

Di Franco M, Gerardi MC, Lucchino B, Conti F

Core Evidence 2014, 9:41-48

Published Date: 12 March 2014

Micafungin: an evidence-based review of its place in therapy

de la Torre P, Reboli AC

Core Evidence 2014, 9:27-39

Published Date: 25 February 2014

Targeted therapy in triple-negative metastatic breast cancer: a systematic review and meta-analysis

Clark O, Botrel TE, Paladini L, Ferreira MB

Core Evidence 2014, 9:1-11

Published Date: 6 January 2014